Sanofi also rejected the idea that Gilles Schnepp — one of the US buyout firm’s operating advisers who has been a Sanofi board member since 2020 — presented a conflict of interest.

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

However, Paul Hudson, CEO of Sanofi, one of the world's leading biopharmaceutical companies, says executives may need to rein ...

Chris Viehbacher has departed from his role as chief executive of Sanofi after the company's board voted to remove him. Having taken over at the Paris-based company six years ago, German-Canadian ...

PARIS (Reuters) -Sanofi on Sunday reached an agreement on ... Bpifrance would take a 1% stake in Opella and hold a seat on ...

French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around 2%, said Sanofi in a statement, and giving the state a seat on Opella's board.

Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. The company's board has approved the Scheme of Arrangement ...

Julien Dodet President of the Governing Board, Orano Med “Sanofi ... as well as gastrointestinal and lung cancers. Sanofi and Orano Med are members of the Paris Saclay Cancer Cluster and ...